COVID-19 Nasal Vaccine Ready for Clinical Trials | Inside Precision Medicine
A new nasal COVID-19 vaccine, CDO-7N-1, is ready for clinical trials, inducing robust mucosal and systemic responses with a single dose, offering protection against all major variants and stable at 4°C for seven months.
Highlighted Terms
Related News
COVID-19 Nasal Vaccine Ready for Clinical Trials | Inside Precision Medicine
A new nasal COVID-19 vaccine, CDO-7N-1, is ready for clinical trials, inducing robust mucosal and systemic responses with a single dose, offering protection against all major variants and stable at 4°C for seven months.